Oxford Nanopore Technologies (LON:ONT) Shares Up 12.7% – Still a Buy?

Oxford Nanopore Technologies plc (LON:ONT) traded up 12.7% on Wednesday . The stock traded as high as GBX 142.20 and last traded at GBX 137.74. 261,358,125 shares traded hands during mid-day trading, an increase of 2,227% from the average session volume of 11,230,706 shares. The stock had previously closed at GBX 122.20.

Analyst Ratings Changes

ONT has been the subject of several recent research reports. Citigroup lowered shares of Oxford Nanopore Technologies to a “buy” rating in a research note on Monday, July 20th. Peel Hunt reaffirmed a “hold” rating and set a GBX 153 price objective on shares of Oxford Nanopore Technologies in a research report on Monday, July 13th. Royal Bank Of Canada reiterated an “outperform” rating and issued a GBX 225 target price on shares of Oxford Nanopore Technologies in a report on Tuesday, May 26th. Finally, Berenberg Bank lowered their target price on Oxford Nanopore Technologies from GBX 220 to GBX 200 and set a “buy” rating for the company in a research note on Wednesday. Four research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of GBX 200.75.

Oxford Nanopore Technologies Trading Up 12.7%

The stock has a market cap of £1.34 billion, a price-to-earnings ratio of -9.12 and a beta of 0.91. The business’s 50 day moving average is GBX 118.16 and its 200 day moving average is GBX 122.69. The company has a debt-to-equity ratio of 8.96, a current ratio of 3.56 and a quick ratio of 6.01.

Oxford Nanopore Technologies (LON:ONT) last released its quarterly earnings data on Wednesday, August 19th. The company reported GBX (4.90) earnings per share (EPS) for the quarter. Oxford Nanopore Technologies had a negative return on equity of 29.43% and a negative net margin of 64.85%.

About Oxford Nanopore Technologies

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.